LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research


The latest company to emerge from Flagship VentureLabs, VL46 is a platform technology pioneering novel insights into viruses to develop novel therapeutics, based on strong foundational IP developed within the Flagship Pioneering innovation foundry. VL46 follows in the footsteps of VentureLabs companies such as Moderna Therapeutics, Seres Therapeutics, Rubius Therapeutics, and Evelo Therapeutics.

VL46 logo
Website - Coming Soon
  • Noubar Afeyan, PhD
  • Avak Kahvejian, PhD
  • Erica Weinstein, PhD
  • Nicholas Plugis, PhD